Mark A. Glickman
Overview
Mark A. Glickman received an average of $1M in total compensation, including $329K in salary, at Aralez Pharmaceuticals from 2015 to 2017.
Source: SEC filings on May 18, 2018 and March 23, 2017.
Related executives
We found five more executives who work or worked at Aralez Pharmaceuticals.
Adrian Adams
Aralez Pharmaceuticals
Chief Executive Officer
Scott Charles
Aralez Pharmaceuticals
Chief Financial Officer
Andrew Koven
Aralez Pharmaceuticals
President and Chief Business Officer
James Tursi
Aralez Pharmaceuticals
Chief Medical Officer
Michael Kaseta
Aralez Pharmaceuticals